Clinical Trial Update: Evaluate the Use of Glibenclamide on Acute aSAH [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the use of glibenclamide for subarachnoid hemorrhage is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Subarachnoid Hemorrhage | Phase 4 | Status: UNKNOWN